It has begun trading as of Feb. 13 under the ticker symbol “AMDA,” according to news release.
The company is also granting a 30-day opportunity to its underwriters to purchase up to 525,000 additional shares of common stock at the IPO price minus an underwriting discount, according to the release.
The offering will likely close Feb. 19.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
